Publications by authors named "Sachiko Morisaki"
Article Synopsis
- Olaparib, a PARP inhibitor effective for certain cancers, has been linked to a rare but severe side effect known as drug-induced interstitial lung disease (DIILD), highlighting the need for awareness and early detection.
- This report details three cases of Japanese women with ovarian cancer who developed DIILD after taking olaparib, with symptoms ranging from fever to severe respiratory issues.
- All patients discontinued olaparib, and treatment varied based on the severity of their conditions, underscoring the importance of monitoring lung health in patients receiving this medication.
Background: Mitotically active cellular fibroma (MACF) of the ovary, characterized by relatively high mitotic activity without severe atypia, represents a relatively new disease entity. MACF is categorized as a benign ovarian tumor. However, due to a limited number of case reports, its clinical and pathological features and optimum management remains largely undetermined.
View Article and Find Full Text PDF